January 9,2025 Update
Precision cancer medicine is a part of cancer genomic medicine. It is a national policy. Our hospital had prepared for the precision cancer treatment and genomic medicine was established at our hospital in April 2019. In our department, we provide medical tests and advise with the aim of optimally delivering this cancer genomic medicine to patients.
Our aim is finding optimal cancer treatment by using cancer gene panel tests. The tests are conducted, covered by health insurance or at the patient’s own cost, to find out if there are drugs (anticancer drugs) that would be effective for the patient’s cancer.
Cancer gene panel testing is likely to progress rapidly in the future, and cancer genome treatment systems are expected to further evolve, so our department is working on a system that can respond quickly to that movement.
As a result of precision cancer medicine, hereditary tumors may be found which need to be handled appropriately. In other words, patients with hereditary tumors, as well as their families, may need different treatments, testing, and support from those for general cancer. Since before the spread of precision cancer medicine, our hospital has actively supported the treatment of hereditary tumors in coordination with the Department of Digestive Tract and General Surgery for hereditary tumors. In particular, our experience in the treatment of Lynch syndrome and familial adenomatous polyposis, both of which are representative hereditary colorectal cancer syndromes, ranks as one of the top in Japanese institutions.
Specialists and certified genetic counselors are responsible for providing precision cancer medicine for patients with hereditary tumors and their families. Further, we also deal with non-cancer hereditary diseases (including suspected cases), so please feel free to contact us regarding these issues.
1. Diagnosis and treatment of hereditary tumors
Characteristics of hereditary tumor patients include multiple cases of the same
cancer (multiple occurrences), carcinogenesis of various organs (multiplicity), carcinogenesis during
youth (youth onset), or when there are many cases of cancer in a family (family clustering), etc. Not
only does this require appropriate diagnosis, treatment, and regular health management of the patients
themselves, but also appropriate surveillance may be necessary for relatives with the same conditions.
Typical hereditary tumors can be genetically diagnosed with genetic test using blood samples. Although
genetic diagnosis of patients with some hereditary tumors is done at their own cost, some diseases can
also be done as research.
We also support patients and their families who have found hereditary tumors through precision cancer
medicine such as cancer genome gene panel testing, etc.
Our department consults on the following hereditary tumors, but we may refer to other medical
departments for the actual medical care and examinations.
Hereditary tumors that can be supported
Please feel free to contact us if you have any questions about cancer and heredity, such as:
Many of my family and relatives have suffered from cancer, and I'm worried that I’m going to have
cancer too, or
Many of my family and relatives have suffered from cancer, and I'm worried that I’m going to have
cancer too, or
2. Diagnosis and treatment of non-tumor hereditary diseases
We can consult about hereditary metabolic diseases and neurological disorders in adults, excluding obstetrics and pediatrics. Although we do not perform genetic diagnosis, treatment, or periodic examination of these non-tumor hereditary diseases, we can refer to medical departments in the hospital and other medical institutions.
Clinical genetic specialists and familial oncologists are in charge of the treatment, and a dedicated
certified genetic counselor provides genetic counseling.
Genetic diagnosis and genetic counseling fees: in general,at the patient’s own cost (except when
participating in research)
Target patients
There may be cases with various symptoms, or there may be no symptoms. Also, there are some, even among those who are susceptible to hereditary diseases, who have not yet developed or do not have the disease, and some who will not develop it for the rest of their lives.
■Regarding genetic counseling costs
The genetic counseling fee is 5,500 yen (including tax) per visit.
Counseling may be done as research depending on the disease.
■Regarding the cost of cancer genomic medicine, please refer to the application method for cancer genomic medicine on the medical department website.
Name | Job Title | Position | Specialized Field | Credentials |
---|---|---|---|---|
石田 秀行 (Ishida Hideyuki) |
Professor | Chief of Clinical Services | General Surgery (Colorectlal surgery) Hereditary colorectal cancer Cancer Chemotherapy |
Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Faculty(tentative), Subspecialty Board of Medical Oncology, JSMO Board Certified oncological geneticist/ Instructor (The Japanese Society for Hereditary Tumors ) |
鈴木 興秀 (Suzuki Okihide) |
Assistant Professor | Chief of Research | General Surgery Hereditary cancer |
Board Certified Surgeon (Jpn Surg Assoc) Board Certified oncological geneticist/ Instructor (The Japanese Society for Hereditary Tumors ) Board Certified Clinical Geneticists (The Japanese Board of Medical Genetics and Genomics Clinical Genetics) |
母里 淑子 (Mori Yoshiko) |
Assistant Professor | General Surgery Hereditary colorectal cancer Cancer Chemotherapy |
Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Board Certified oncological geneticist (The Japanese Society for Hereditary Tumors) Board Certified Clinical Geneticists (The Japanese Board of Medical Genetics and Genomics Clinical Genetics) |
|
田辺 記子 (Tanabe Noriko) |
Assistant Professor | Intractable Disease Support Counseling | Certified Genetic Counselors (The Japan Society of Human Genetics and Japanese Society for Genetic Counseling ) | |
北山 沙知 (Kitayama Sachi) |
Assistant Professor | Genitourinary cancer Clinical genetics Robot-assisted surgery |
Board Certified oncological geneticist/ Instructor (The Japanese Society for Hereditary Tumors) Japanese Board Certified Urologist/Instructor General Clinical Oncologist (by JBCT) |
|
吉田 輝彦 (Yoshida Teruhiko) |
Visiting Professor | Intractable Disease Support Counseling | Certified Genetic Counselors (The Japan Society of Human Genetics and Japanese Society for Genetic Counseling ) |
|
構 奈央 (Kamae Nao) |
Part-time genetic counselor | Intractable Disease Support Counseling | Certified Genetic Counselors(The Japan Society of Human Genetics and Japanese Society for Genetic Counseling ) |
Department of Clinical Genetics | ||||||
月曜日 Monday |
火曜日 Tuesday |
水曜日 Wednesday |
木曜日 Thursday |
金曜日 Friday |
土曜日 Saturday |
|
午後 | ||||||
専門外来 |
鈴木 興秀 (Suzuki Okihide) |
鈴木 興秀 (Suzuki Okihide) |
鈴木 興秀 (Suzuki Okihide) |
|||
専門外来 |
母里 淑子 (Mori Yoshiko) |
母里 淑子 (Mori Yoshiko) |
||||
田辺 記子 (Tanabe Noriko) |
||||||
石田 秀行 (Ishida Hideyuki) |
水曜日 午前 (9:00-11:30)
・がんゲノム医療受診前調査 ・遺伝性腫瘍外来
水曜日 午後 (13:00-16:00)
・がんゲノム医療外来
・遺伝性疾患外来
担当医:石田 秀行、鈴木 興秀、母里 淑子
担当遺伝カウンセラー:田辺 記子、構 奈央
その他の曜日をご希望の場合は個別にご相談ください。
当外来は予約制になっております。患者さんご本人または主治医の先生より当科スタッフまでご連絡ください。
Wednesday Morning (9:00 am - 11:30 am)
・ Cancer genomic medicine pre-examination
Wednesday Afternoon (1:00 pm - 4:00 pm)
・ Cancer genomic medicine outpatient
・ Hereditary disease outpatient
Physicians in charge: Hideyuki Ishida, Okihide Suzuki, Yoshiko Mori
Genetic Counselor in charge: Nao Kamae
Please contact us individually if you would like to meet on another day of the week.
Our outpatient is by reservation only. Patients themselves or their doctors can contact our staff.
[Overview of outpatient application method for cancer genomic medicine]Please go to the Medical Department website for details and application documents.
These are basically patients with rare cancers, cancers with unknown origin, and cancers where
standard treatment has ended.
Those who are in good physical condition (ECOG PS = 2 or less) and who can continue drug therapy
(anti-cancer drugs and molecular targeted drugs) are eligible.
This applies to patients who are ineligible for or expected to be intolerant of standard
treatment.
For conditions other than the above, patients should please contact us individually.
Contact us:049-228-3619